Tornier (NASDAQ: TRNX), is a global medical device company focused on providing solutions to surgeons who treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. The Company's broad offering of over 95 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee. The company’s strategy is to become the leading orthopaedic company focused on extremities.
In July 2006, Warburg Pincus acquired Tornier from Alain Tornier, the company’s former President and owner. During 2007, Warburg Pincus provided financing for the company to complete several strategic acquisitions to broaden its portfolio of products for shoulder surgeons and other extremity specialists. On February 2, 2011, Tornier completed its initial public offering on NASDAQ. On October 4, 2012, Tornier completed its acquisition of OrthoHelix, an innovative high-growth orthopaedics company focused on lower extremity products.
Back to Previous Page